Adora Ndu
Vermogen: 838 456 $ op 30-06-2026
Vermogen: 838 456 $ op 30-06-2026
Dr. Adora Ndu is VP-World Wide Research & Development bij BioMarin Pharmaceutical, Inc. Zij zetelt in de Raad van Bestuur van DBV Technologies SA. Dr. Ndu was voorheen werkzaam als lid van de Universiteit van Maryland. Zij behaalde haar diploma aan de Francis King Carey School of Law van de Universiteit van Maryland en haar doctoraat aan het Howard University College of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-05-2026 | 32.908 ( 0,02% ) | 832 572 $ | 30-06-2026 | |
| 15-04-2026 | 1.825 ( 0% ) | 5 884 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| DBV TECHNOLOGIES | Directeur/Bestuurslid | 19-05-2021 |
| BRIDGEBIO PHARMA, INC. | Algemeen Adviseur | 01-01-2022 |
| ACADIA PHARMACEUTICALS INC. | Directeur/Bestuurslid | 10-10-2022 |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2022 |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Corporate Officer/Principal | 01-01-2016 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
ACADIA Pharmaceuticals, Inc.
ACADIA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals drugs for treatment of central nervous system disorders | Health Technology |
DBV Technologies SA
DBV Technologies SA Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that focuses on changing the field of immunotherapy | Health Technology |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment Operates agencies to protect health and human services | Government |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
The University of Maryland Francis King Carey School of Law
The University of Maryland Francis King Carey School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Howard University College of Medicine
Howard University College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau